疑似缺氧缺血性脑病机械通气成人患者的保守氧疗:一项事后分析
该研究为一项比较保守氧疗与常规氧疗的随机试验的事后分析,纳入166例疑似缺氧缺血性脑病的机械通气ICU患者。主要终点为180天死亡或不良神经结局,保守氧疗组55.1% vs 常规氧疗组68.1%,OR 0.58(95%CI 0.3-1.12,P=0.1),未达统计学显著。180天死亡率保守氧疗组43% vs 常规氧疗组59%,OR 0.53(95%CI 0.28-0.98,P=0.04),但校正后OR 0.56(95%CI 0.25-1.23,P=0.15)未达显著。作者结论认为保守氧疗未显著改善主要终点,但不能排除重要获益或危害。
要点
- 在疑似缺氧缺血性脑病的机械通气患者中,保守氧疗组180天死亡或不良神经结局55.1%,常规氧疗组68.1%,OR 0.58(95%CI 0.3-1.12,P=0.1),未达统计学显著。
- 180天死亡率保守氧疗组43% vs 常规氧疗组59%,OR 0.53(95%CI 0.28-0.98,P=0.04),但校正后OR 0.56(95%CI 0.25-1.23,P=0.15)未达显著。
- 保守氧疗组在ICU内SpO2≥97%的时间为26小时(IQR 13-45),常规氧疗组为35小时(IQR 19-70),绝对差9小时(95%CI -21.4至3.4)。
- 两组病因特异性死亡率相似。
- 作者结论:保守氧疗未显著降低180天死亡或不良神经结局,但不能排除重要获益或危害。
适用人群与场景
- 纳入1000例机械通气ICU患者中166例疑似缺氧缺血性脑病患者进行事后分析。
研究设计与关键结果
- 研究类型:一项比较保守氧疗与常规氧疗的随机试验的事后分析,纳入166例疑似缺氧缺血性脑病的机械通气患者。
- 主要终点(180天死亡或不良神经结局):保守氧疗组43/78例(55.1%)vs 常规氧疗组49/72例(68.1%),OR 0.58(95%CI 0.3-1.12,P=0.1),校正OR 0.54(95%CI 0.23-1.26,P=0.15)。
- 关键次要终点(180天死亡率):保守氧疗组37/86例(43%)vs 常规氧疗组46/78例(59%),OR 0.53(95%CI 0.28-0.98,P=0.04),校正OR 0.56(95%CI 0.25-1.23,P=0.15)。
- ICU内SpO2≥97%时间:保守氧疗组26小时(IQR 13-45)vs 常规氧疗组35小时(IQR 19-70),绝对差9小时(95%CI -21.4至3.4)。
- 病因特异性死亡率两组相似。
证据类型、等级与局限
- 证据类型:随机试验的事后分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论:保守氧疗未显著降低180天死亡或不良神经结局,但不能排除对缺氧缺血性脑病患者的重要获益或危害。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: Liberal use of oxygen may contribute to secondary brain injury in patients with hypoxic-ischaemic encephalopathy (HIE). However, there are limited data on the effect of different oxygen regimens on survival and neurological disability in HIE patients.
METHODS: We undertook a post-hoc analysis of the 166 patients with suspected HIE enrolled in a trial comparing conservative oxygen therapy with usual oxygen therapy in 1000 mechanically ventilated ICU patients. The primary endpoint for the current analysis was death or unfavourable neurological outcome at day 180. Key secondary outcomes were day 180 mortality, and cause-specific mortality.
RESULTS: Patients with HIE allocated to conservative oxygen spent less time in the ICU with an SpO2 ≥ 97% (26 h [interquartile range (IQR) 13-45 vs. 35 h [IQR 19-70], absolute difference, 9 h; 95% CI - 21.4 to 3.4). A total of 43 of 78 patients (55.1%) assigned to conservative oxygen and 49 of 72 patients (68.1%) assigned to usual oxygen died or had an unfavourable neurological outcome at day 180; odds ratio 0.58; 95% CI 0.3-1.12; P = 0.1 adjusted odds ratio 0.54; 95% CI 0.23-1.26; P = 0.15. A total of 37 of 86 patients (43%) assigned to conservative oxygen and 46 of 78 (59%) assigned to usual oxygen had died by day 180; odds ratio 0.53; 95% CI 0.28-0.98; P = 0.04; adjusted odds ratio 0.56; 95% CI 0.25-1.23; P = 0.15. Cause-specific mortality was similar by treatment group.
CONCLUSIONS: Conservative oxygen therapy was not associated with a statistically significant reduction in death or unfavourable neurological outcomes at day 180. The potential for important benefit or harm from conservative oxygen therapy in HIE patients is not excluded by these data.
参考来源
- Young P, Mackle D, Bellomo R, et al. Conservative oxygen therapy for mechanically ventilated adults with suspected hypoxic ischaemic encephalopathy. Intensive Care Med. 2020. PMID: 32809136. doi:10.1007/s00134-020-06196-y
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。